首页 > 最新文献

Journal of Toxicology and Environmental Health-Part B-Critical Reviews最新文献

英文 中文
Dermal absorption of cyclic and linear siloxanes: a review. 环状和线性硅氧烷的皮肤吸收:综述。
IF 7.2 2区 医学 Q1 ENVIRONMENTAL SCIENCES Pub Date : 2024-04-02 Epub Date: 2024-02-20 DOI: 10.1080/10937404.2024.2316843
Harvey Clewell, Tracy Greene, Robinan Gentry

Cyclic and linear siloxanes are compounds synthesized from silicon consisting of alternating atoms of silicone and oxygen [Si-O] units with organic side chains. The most common cyclic siloxanes are octamethylcyclotetrasiloxane (D4), decamethylcyclopentasiloxane (D5), and dodecamethylcyclohexasiloxane (D6), while the most common linear siloxanes are high molecular weight polydimethylsiloxanes (PDMS) and low molecular weight volatile linear siloxanes known as hexamethyldisiloxane (L2), octamethyltrisiloxane (L3), decamethyltetrasiloxane (L4), dodecamethylpentasiloxane (L5). These compounds (1) exhibit low dermal toxicity, (2) are generally inert and non-reactive, and (3) are compatible with a wide range of chemicals offering beneficial chemical properties which include the following: wash-off or transfer resistance from the skin, sun protection factor (SPF) enhancement, emolliency in cleaning products). Because of these properties, these compounds are incorporated into multiple consumer products for use on the skin, such as cosmetics and health-care products, with over 300,000 tons annually sold into the personal care and consumer products sector. Because of their widespread use in consumer products and potential for human dermal exposure, a comprehensive understanding of the dermal absorption and overall fate of siloxanes following dermal exposure is important. This review summarizes available data associated with the dermal absorption/penetration as well as fate of the most commonly used siloxane substances.

环状和线状硅氧烷是由硅合成的化合物,由硅原子和氧原子[Si-O]单元交替组成,并带有有机侧链。最常见的环状硅氧烷是八甲基环四硅氧烷(D4)、十甲基环五硅氧烷(D5)和十二甲基环六硅氧烷(D6)、而最常见的线性硅氧烷是高分子量的聚二甲基硅氧烷(PDMS)和低分子量的挥发性线性硅氧烷,称为六甲基二硅氧烷(L2)、八甲基三硅氧烷(L3)、十甲基四硅氧烷(L4)和十二甲基五硅氧烷(L5)。这些化合物(1) 皮肤毒性低,(2) 一般为惰性,无反应,(3) 可与多种化学品兼容,具有以下有益的化学特性:耐洗或耐皮肤转移,提高防晒系数 (SPF),在清洁产品中具有润肤效果)。由于这些特性,这些化合物被用于多种皮肤消费品中,如化妆品和保健品,每年在个人护理和消费品领域的销售量超过 30 万吨。由于硅氧烷在消费品中的广泛应用以及人体皮肤接触硅氧烷的可能性,因此全面了解皮肤对硅氧烷的吸收情况以及皮肤接触硅氧烷后的总体归宿非常重要。本综述总结了与最常用硅氧烷物质的皮肤吸收/渗透和最终结果相关的现有数据。
{"title":"Dermal absorption of cyclic and linear siloxanes: a review.","authors":"Harvey Clewell, Tracy Greene, Robinan Gentry","doi":"10.1080/10937404.2024.2316843","DOIUrl":"10.1080/10937404.2024.2316843","url":null,"abstract":"<p><p>Cyclic and linear siloxanes are compounds synthesized from silicon consisting of alternating atoms of silicone and oxygen [Si-O] units with organic side chains. The most common cyclic siloxanes are octamethylcyclotetrasiloxane (D4), decamethylcyclopentasiloxane (D5), and dodecamethylcyclohexasiloxane (D6), while the most common linear siloxanes are high molecular weight polydimethylsiloxanes (PDMS) and low molecular weight volatile linear siloxanes known as hexamethyldisiloxane (L2), octamethyltrisiloxane (L3), decamethyltetrasiloxane (L4), dodecamethylpentasiloxane (L5). These compounds (1) exhibit low dermal toxicity, (2) are generally inert and non-reactive, and (3) are compatible with a wide range of chemicals offering beneficial chemical properties which include the following: wash-off or transfer resistance from the skin, sun protection factor (SPF) enhancement, emolliency in cleaning products). Because of these properties, these compounds are incorporated into multiple consumer products for use on the skin, such as cosmetics and health-care products, with over 300,000 tons annually sold into the personal care and consumer products sector. Because of their widespread use in consumer products and potential for human dermal exposure, a comprehensive understanding of the dermal absorption and overall fate of siloxanes following dermal exposure is important. This review summarizes available data associated with the dermal absorption/penetration as well as fate of the most commonly used siloxane substances.</p>","PeriodicalId":49971,"journal":{"name":"Journal of Toxicology and Environmental Health-Part B-Critical Reviews","volume":" ","pages":"106-129"},"PeriodicalIF":7.2,"publicationDate":"2024-04-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139906765","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Occupational exposure to endotoxins and small cell lung cancer: a systematic review with meta-analysis. 职业性接触内毒素与小细胞肺癌:系统回顾与荟萃分析。
IF 6.4 2区 医学 Q1 ENVIRONMENTAL SCIENCES Pub Date : 2024-04-02 Epub Date: 2024-02-18 DOI: 10.1080/10937404.2024.2316151
Nerea Mourino, Leonor Varela-Lema, Alberto Ruano-Ravina, Cristina Peiteado, Cristina Candal-Pedreira, Julia Rey-Brandariz, Eliana Torres-Cadavid, Guadalupe García, Mónica Pérez-Ríos

The relationship of occupational exposure to endotoxins with different histologic subtypes of lung cancer has not been established. Our objective was to conduct a systematic review with meta-analysis to assess the effect of exposure to endotoxins on the development of small cell lung cancer (SCLC). A bibliographic search was conducted using MEDLINE, Embase, CENTRAL, and Web of Science databases until December 2022, including all cohort and/or case-control studies that examined occupational exposure to endotoxins and SCLC. Risk of bias was assessed using the U.S. Office of Health Assessment and Translation tool. A random effects model was applied, publication bias were assessed, and a sensitivity analysis was conducted. Four papers were selected for meta-analysis purposes. A total of 144 incident cases of SCLC and 897 population or hospital controls were included. Occupational exposure to endotoxins was considered for textile/leather industry and agricultural sector workers exposed to endotoxins originating from wool, cotton, or leather dust. Except for one study, all investigations were classified as having a low probability of risk of biases. The results of the meta-analysis were not statistically significant (pooled OR: 0.86; 95% CI:0.69-1.08). In addition, neither between-study heterogeneity (I2=0%;p=0.92) nor publication bias was observed (p=0.49). The results of the sensitivity analysis, after including five studies that assessed the risk of SCLC among textile industry and crop/livestock farm workers (not specifically exposed to endotoxins), showed a negative statistically non-significant association and low between-study heterogeneity (pooled OR: 0.90; 95% CI:0.79-1.02; I2=22%;p=0.23). Subjects exposed to occupational exposure to endotoxins seem to exhibit a negative association with the development of SCLC, although the results are not conclusive.

职业性接触内毒素与不同组织学亚型肺癌之间的关系尚未确定。我们的目的是通过荟萃分析进行系统综述,评估接触内毒素对小细胞肺癌(SCLC)发病的影响。我们使用MEDLINE、Embase、CENTRAL和Web of Science数据库进行了文献检索,包括所有研究职业暴露于内毒素和小细胞肺癌的队列研究和/或病例对照研究,直至2022年12月。采用美国健康评估与转化办公室的工具对偏倚风险进行了评估。采用随机效应模型,评估了发表偏倚,并进行了敏感性分析。最后选择了四篇论文进行荟萃分析。共纳入了 144 例 SCLC 发病病例和 897 例人群或医院对照病例。考虑了纺织/皮革业和农业部门工人接触羊毛、棉花或皮革粉尘内毒素的情况。除一项研究外,所有调查均被归类为偏差风险概率较低。荟萃分析的结果没有统计学意义(汇总 OR:0.86;95% CI:0.69-1.08)。此外,既未观察到研究间异质性(I2=0%;P=0.92),也未观察到发表偏倚(P=0.49)。敏感性分析包括了五项评估纺织业和作物/畜牧业工人(并非专门暴露于内毒素)罹患SCLC风险的研究,结果显示两者之间存在统计学意义上不显著的负相关,且研究间异质性较低(汇总OR:0.90;95% CI:0.79-1.02;I2=22%;p=0.23)。职业性接触内毒素的受试者似乎与鳞状细胞癌的发病呈负相关,但结果尚不确定。
{"title":"Occupational exposure to endotoxins and small cell lung cancer: a systematic review with meta-analysis.","authors":"Nerea Mourino, Leonor Varela-Lema, Alberto Ruano-Ravina, Cristina Peiteado, Cristina Candal-Pedreira, Julia Rey-Brandariz, Eliana Torres-Cadavid, Guadalupe García, Mónica Pérez-Ríos","doi":"10.1080/10937404.2024.2316151","DOIUrl":"10.1080/10937404.2024.2316151","url":null,"abstract":"<p><p>The relationship of occupational exposure to endotoxins with different histologic subtypes of lung cancer has not been established. Our objective was to conduct a systematic review with meta-analysis to assess the effect of exposure to endotoxins on the development of small cell lung cancer (SCLC). A bibliographic search was conducted using MEDLINE, Embase, CENTRAL, and Web of Science databases until December 2022, including all cohort and/or case-control studies that examined occupational exposure to endotoxins and SCLC. Risk of bias was assessed using the U.S. Office of Health Assessment and Translation tool. A random effects model was applied, publication bias were assessed, and a sensitivity analysis was conducted. Four papers were selected for meta-analysis purposes. A total of 144 incident cases of SCLC and 897 population or hospital controls were included. Occupational exposure to endotoxins was considered for textile/leather industry and agricultural sector workers exposed to endotoxins originating from wool, cotton, or leather dust. Except for one study, all investigations were classified as having a low probability of risk of biases. The results of the meta-analysis were not statistically significant (pooled OR: 0.86; 95% CI:0.69-1.08). In addition, neither between-study heterogeneity (I<sup>2</sup>=0%;p=0.92) nor publication bias was observed (p=0.49). The results of the sensitivity analysis, after including five studies that assessed the risk of SCLC among textile industry and crop/livestock farm workers (not specifically exposed to endotoxins), showed a negative statistically non-significant association and low between-study heterogeneity (pooled OR: 0.90; 95% CI:0.79-1.02; I<sup>2</sup>=22%;p=0.23). Subjects exposed to occupational exposure to endotoxins seem to exhibit a negative association with the development of SCLC, although the results are not conclusive.</p>","PeriodicalId":49971,"journal":{"name":"Journal of Toxicology and Environmental Health-Part B-Critical Reviews","volume":" ","pages":"91-105"},"PeriodicalIF":6.4,"publicationDate":"2024-04-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139900805","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effects associated with exposure to the emerging contaminant octyl-methoxycinnamate (a UV-B filter) in the aquatic environment: a review. 与接触水生环境中新出现的污染物辛基甲氧基肉桂酸酯(一种紫外线-B 过滤器)有关的影响:综述。
IF 7.2 2区 医学 Q1 ENVIRONMENTAL SCIENCES Pub Date : 2024-02-17 Epub Date: 2024-01-26 DOI: 10.1080/10937404.2023.2296897
Margarida Lorigo, Carla Quintaneiro, Luiza Breitenfeld, Elisa Cairrao

Given the increasing concern surrounding ultraviolet (UV) radiation-induced skin damage, there has been a rise in demand for UV filters. Currently, UV-filters are considered emerging contaminants. The extensive production and use of UV filters have led to their widespread release into the aquatic environment. Thus, there is growing concern that UV filters may bioaccumulate and exhibit persistent properties within the environment, raising several safety health concerns. Octyl-methoxycinnamate (OMC) is extensively employed as a UV-B filter in the cosmetic industry. While initially designed to mitigate the adverse photobiological effects attributed to UV radiation, the safety of OMC has been questioned with some studies reporting toxic effects on environment. The aim of this review to provide an overview of the scientific information regarding the most widely used organic UV-filter (OMC), and its effects on biodiversity and aquatic environment.

由于人们越来越关注紫外线(UV)辐射对皮肤造成的伤害,对紫外线过滤器的需求也随之增加。目前,紫外线过滤器被认为是新出现的污染物。紫外线过滤器的广泛生产和使用已导致其广泛释放到水生环境中。因此,人们越来越担心紫外线滤光器可能会在环境中进行生物累积并表现出持久性,从而引发一些安全健康问题。化妆品行业广泛使用甲氧基肉桂酸辛酯(OMC)作为紫外线-B 过滤器。虽然最初设计的目的是为了减轻紫外线辐射对光生物的不利影响,但 OMC 的安全性一直受到质疑,一些研究报告称 OMC 对环境有毒害作用。本综述旨在概述有关最广泛使用的有机紫外线过滤器(OMC)及其对生物多样性和水生环境影响的科学信息。
{"title":"Effects associated with exposure to the emerging contaminant octyl-methoxycinnamate (a UV-B filter) in the aquatic environment: a review.","authors":"Margarida Lorigo, Carla Quintaneiro, Luiza Breitenfeld, Elisa Cairrao","doi":"10.1080/10937404.2023.2296897","DOIUrl":"10.1080/10937404.2023.2296897","url":null,"abstract":"<p><p>Given the increasing concern surrounding ultraviolet (UV) radiation-induced skin damage, there has been a rise in demand for UV filters. Currently, UV-filters are considered emerging contaminants. The extensive production and use of UV filters have led to their widespread release into the aquatic environment. Thus, there is growing concern that UV filters may bioaccumulate and exhibit persistent properties within the environment, raising several safety health concerns. Octyl-methoxycinnamate (OMC) is extensively employed as a UV-B filter in the cosmetic industry. While initially designed to mitigate the adverse photobiological effects attributed to UV radiation, the safety of OMC has been questioned with some studies reporting toxic effects on environment. The aim of this review to provide an overview of the scientific information regarding the most widely used organic UV-filter (OMC), and its effects on biodiversity and aquatic environment.</p>","PeriodicalId":49971,"journal":{"name":"Journal of Toxicology and Environmental Health-Part B-Critical Reviews","volume":" ","pages":"55-72"},"PeriodicalIF":7.2,"publicationDate":"2024-02-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139038088","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Standardized guidelines for Africanized honeybee venom production needed for development of new apilic antivenom. 非洲化蜜蜂毒液生产标准化指南对开发新的蜂毒抗血清十分必要。
IF 7.2 2区 医学 Q1 ENVIRONMENTAL SCIENCES Pub Date : 2024-02-17 Epub Date: 2024-01-26 DOI: 10.1080/10937404.2023.2300786
Ricardo Oliveira Orsi, Rodrigo Zaluski, Luciana Curtolo de Barros, Benedito Barraviera, Daniel Carvalho Pimenta, Rui Seabra Ferreira Junior

Africanized bees have spread across the Americas since 1956 and consequently resulted in human and animal deaths attributed to massive attacks related to exposure from Argentina to the USA. In Brazil, more than 100,000 accidents were registered in the last 5 years with a total of 303 deaths. To treat such massive attacks, Brazilian researchers developed the first specific antivenom against Africanized honey bee sting exposure. This unique product, the first of its kind in the world, has been safely tested in 20 patients during a Phase 2 clinical trial. To develop the antivenom, a standardized process was undertaken to extract primary venom antigens from the Africanized bees for immunization of serum-producing horses. This process involved extracting, purifying, fractionating, characterizing, and identifying the venom (apitoxin) employing mass spectrometry to generate standardized antigen for hyperimmunization of horses using the major toxins (melittin and its isoforms and phospholipase A2). The current guide describes standardization of the entire production chain of venom antigens in compliance with good manufacturing practices (GMP) required by regulatory agencies. Emphasis is placed upon the welfare of bees and horses during this process, as well as the development of a new biopharmaceutical to ultimately save lives.

自 1956 年以来,非洲化蜜蜂遍布美洲,从阿根廷到美国,大规模的攻击导致人类和动物死亡。在巴西,过去 5 年中登记在册的事故超过 10 万起,共有 303 人死亡。为了治疗这种大规模的螫伤,巴西研究人员研制出了第一种针对非洲化蜜蜂螫伤的特效抗血清。这种独特的产品是世界上首创,在第二阶段临床试验中对 20 名患者进行了安全测试。为了开发抗蛇毒血清,公司采用了标准化流程,从非洲化蜜蜂中提取主要毒液抗原,用于生产血清的马匹的免疫接种。这一过程包括提取、纯化、分馏、表征和使用质谱法鉴定毒液(蛛毒素),以生成标准化抗原,用于使用主要毒素(美立汀及其异构体和磷脂酶 A2)对马进行超免疫。本指南介绍了按照监管机构要求的良好生产规范(GMP)对毒液抗原整个生产链进行标准化的情况。重点是这一过程中蜜蜂和马的福利,以及最终拯救生命的新型生物制药的开发。
{"title":"Standardized guidelines for Africanized honeybee venom production needed for development of new apilic antivenom.","authors":"Ricardo Oliveira Orsi, Rodrigo Zaluski, Luciana Curtolo de Barros, Benedito Barraviera, Daniel Carvalho Pimenta, Rui Seabra Ferreira Junior","doi":"10.1080/10937404.2023.2300786","DOIUrl":"10.1080/10937404.2023.2300786","url":null,"abstract":"<p><p>Africanized bees have spread across the Americas since 1956 and consequently resulted in human and animal deaths attributed to massive attacks related to exposure from Argentina to the USA. In Brazil, more than 100,000 accidents were registered in the last 5 years with a total of 303 deaths. To treat such massive attacks, Brazilian researchers developed the first specific antivenom against Africanized honey bee sting exposure. This unique product, the first of its kind in the world, has been safely tested in 20 patients during a Phase 2 clinical trial. To develop the antivenom, a standardized process was undertaken to extract primary venom antigens from the Africanized bees for immunization of serum-producing horses. This process involved extracting, purifying, fractionating, characterizing, and identifying the venom (apitoxin) employing mass spectrometry to generate standardized antigen for hyperimmunization of horses using the major toxins (melittin and its isoforms and phospholipase A2). The current guide describes standardization of the entire production chain of venom antigens in compliance with good manufacturing practices (GMP) required by regulatory agencies. Emphasis is placed upon the welfare of bees and horses during this process, as well as the development of a new biopharmaceutical to ultimately save lives.</p>","PeriodicalId":49971,"journal":{"name":"Journal of Toxicology and Environmental Health-Part B-Critical Reviews","volume":" ","pages":"73-90"},"PeriodicalIF":7.2,"publicationDate":"2024-02-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139511961","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Systemic health effects of noise exposure. 噪音暴露对全身健康的影响。
IF 7.2 2区 医学 Q1 ENVIRONMENTAL SCIENCES Pub Date : 2024-01-02 Epub Date: 2023-11-28 DOI: 10.1080/10937404.2023.2280837
Li Yang, Daniel E Gutierrez, O'neil W Guthrie

Noise, any unwanted sound, is pervasive and impacts large populations worldwide. Investigators suggested that noise exposure not only induces auditory damage but also produces various organ system dysfunctions. Although previous reviews primarily focused on noise-induced cardiovascular and cerebral dysfunctions, this narrow focus has unintentionally led the research community to disregard the importance of other vital organs. Indeed, limited studies revealed that noise exposure impacts other organs including the liver, kidneys, pancreas, lung, and gastrointestinal tract. Therefore, the aim of this review was to examine the effects of noise on both the extensively studied organs, the brain and heart, but also determine noise impact on other vital organs. The goal was to illustrate a comprehensive understanding of the systemic effects of noise. These systemic effects may guide future clinical research and epidemiological endpoints, emphasizing the importance of considering noise exposure history in diagnosing various systemic diseases.

噪音,任何不受欢迎的声音,无处不在,影响着世界各地的大量人口。研究人员认为,噪声暴露不仅会引起听觉损伤,还会引起各种器官系统功能障碍。虽然以前的评论主要集中在噪声引起的心血管和脑功能障碍上,但这种狭隘的关注无意中导致研究界忽视了其他重要器官的重要性。事实上,有限的研究表明,噪音暴露会影响其他器官,包括肝脏、肾脏、胰腺、肺和胃肠道。因此,本综述的目的是检查噪声对被广泛研究的器官,大脑和心脏的影响,但也确定噪声对其他重要器官的影响。目的是阐明对噪声的系统性影响的全面理解。这些系统性影响可以指导未来的临床研究和流行病学终点,强调在诊断各种系统性疾病时考虑噪声暴露史的重要性。
{"title":"Systemic health effects of noise exposure.","authors":"Li Yang, Daniel E Gutierrez, O'neil W Guthrie","doi":"10.1080/10937404.2023.2280837","DOIUrl":"10.1080/10937404.2023.2280837","url":null,"abstract":"<p><p>Noise, any unwanted sound, is pervasive and impacts large populations worldwide. Investigators suggested that noise exposure not only induces auditory damage but also produces various organ system dysfunctions. Although previous reviews primarily focused on noise-induced cardiovascular and cerebral dysfunctions, this narrow focus has unintentionally led the research community to disregard the importance of other vital organs. Indeed, limited studies revealed that noise exposure impacts other organs including the liver, kidneys, pancreas, lung, and gastrointestinal tract. Therefore, the aim of this review was to examine the effects of noise on both the extensively studied organs, the brain and heart, but also determine noise impact on other vital organs. The goal was to illustrate a comprehensive understanding of the systemic effects of noise. These systemic effects may guide future clinical research and epidemiological endpoints, emphasizing the importance of considering noise exposure history in diagnosing various systemic diseases.</p>","PeriodicalId":49971,"journal":{"name":"Journal of Toxicology and Environmental Health-Part B-Critical Reviews","volume":" ","pages":"21-54"},"PeriodicalIF":7.2,"publicationDate":"2024-01-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"92157138","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bioactive alkaloids from the venom of Dendrobatoidea Cope, 1865: a scoping review. 石斛毒中的生物活性生物碱,1865:范围界定综述。
IF 7.2 2区 医学 Q1 ENVIRONMENTAL SCIENCES Pub Date : 2024-01-02 Epub Date: 2023-11-28 DOI: 10.1080/10937404.2023.2270408
Débora Regina Dos Santos Arraes, Alex Bruno Lobato Rodrigues, Patrick Ribeiro Sanches, Carlos Eduardo Costa Campos, Sheylla Susan Moreira da Silva de Almeida, Janaina Reis Ferreira Lima, Jucivaldo Dias Lima, Gabriel Araujo da Silva

Bioactive compounds derived from secondary metabolism in animals have refined selectivity and potency for certain biological targets. The superfamily Dendrobatoidea is adapted to the dietary sequestration and secretion of toxic alkaloids, which play a role in several biological activities, and thus serve as a potential source for pharmacological and biotechnological applications. This article constitutes a scoping review to understand the trends in experimental research involving bioactive alkaloids derived from Dendrobatoidea based upon scientometric approaches. Forty-eight (48) publications were found in 30 journals in the period of 60 years, between 1962 and 2022. More than 23 structural classes of alkaloids were cited, with 27.63% for batrachotoxins, 13.64% for pyridinics, with an emphasis on epibatidine, 16.36% for pumiliotoxins, and 11.82% for histrionicotoxins. These tests included in vivo (54.9%), in vitro (39.4%), and in silico simulations (5.6%). Most compounds (54.8%) were isolated from skin extracts, whereas the remainder were obtained through molecular synthesis. Thirteen main biological activities were identified, including acetylcholinesterase inhibitors (27.59%), sodium channel inhibitors (12.07%), cardiac (12.07%), analgesic (8.62%), and neuromuscular effects (8.62%). The substances were cited as being of natural origin in the "Dendrobatidae" family, genus "Phyllobates," "Dendrobates," and seven species: Epipedobates tricolor, Phyllobates aurotaenia, Oophaga histrionica, Oophaga pumilio, Phyllobates terribilis, Epipedobates anthonyi, and Ameerega flavopicta. To date, only a few biological activities have been experimentally tested; hence, further studies on the bioprospecting of animal compounds and ecological approaches are needed.

源自动物次级代谢的生物活性化合物对某些生物靶标具有精细的选择性和效力。石斛总科适应于有毒生物碱的膳食螯合和分泌,这些生物碱在多种生物活性中发挥作用,因此是药理学和生物技术应用的潜在来源。本文以科学计量学方法为基础,对石斛总科生物活性生物碱的实验研究趋势进行了综述。在60年期间,在30种期刊上发现了四十八(48)种出版物 1962年至2022年。引用了超过23个结构类别的生物碱,其中蝙蝠黄毒素占27.63%,吡啶类占13.64%,重点是表巴蒂定,浮石毒素占16.36%,组胺毒素占11.82%。这些测试包括体内(54.9%)、体外(39.4%)和计算机模拟(5.6%)。大多数化合物(54.8%)是从皮肤提取物中分离出来的,而其余化合物是通过分子合成获得的。鉴定出13种主要生物活性,包括乙酰胆碱酯酶抑制剂(27.59%)、钠通道抑制剂(12.07%)、心脏(12.07%,黄颡鱼、小黄颡虫、terribilis Phyllobates、anthonyi Epipedobates和flavopicta Ameerega。迄今为止,只有少数生物活性经过了实验测试;因此,需要对动物化合物的生物勘探和生态学方法进行进一步的研究。
{"title":"Bioactive alkaloids from the venom of Dendrobatoidea Cope, 1865: a scoping review.","authors":"Débora Regina Dos Santos Arraes, Alex Bruno Lobato Rodrigues, Patrick Ribeiro Sanches, Carlos Eduardo Costa Campos, Sheylla Susan Moreira da Silva de Almeida, Janaina Reis Ferreira Lima, Jucivaldo Dias Lima, Gabriel Araujo da Silva","doi":"10.1080/10937404.2023.2270408","DOIUrl":"10.1080/10937404.2023.2270408","url":null,"abstract":"<p><p>Bioactive compounds derived from secondary metabolism in animals have refined selectivity and potency for certain biological targets. The superfamily Dendrobatoidea is adapted to the dietary sequestration and secretion of toxic alkaloids, which play a role in several biological activities, and thus serve as a potential source for pharmacological and biotechnological applications. This article constitutes a scoping review to understand the trends in experimental research involving bioactive alkaloids derived from Dendrobatoidea based upon scientometric approaches. Forty-eight (48) publications were found in 30 journals in the period of 60 years, between 1962 and 2022. More than 23 structural classes of alkaloids were cited, with 27.63% for batrachotoxins, 13.64% for pyridinics, with an emphasis on epibatidine, 16.36% for pumiliotoxins, and 11.82% for histrionicotoxins. These tests included <i>in vivo</i> (54.9%), <i>in vitro</i> (39.4%), and <i>in silico</i> simulations (5.6%). Most compounds (54.8%) were isolated from skin extracts, whereas the remainder were obtained through molecular synthesis. Thirteen main biological activities were identified, including acetylcholinesterase inhibitors (27.59%), sodium channel inhibitors (12.07%), cardiac (12.07%), analgesic (8.62%), and neuromuscular effects (8.62%). The substances were cited as being of natural origin in the \"Dendrobatidae\" family, genus \"<i>Phyllobates</i>,\" \"<i>Dendrobates</i>,\" and seven species: <i>Epipedobates tricolor</i>, <i>Phyllobates aurotaenia</i>, <i>Oophaga histrionica</i>, <i>Oophaga pumilio</i>, <i>Phyllobates terribilis</i>, <i>Epipedobates anthonyi</i>, and <i>Ameerega flavopicta</i>. To date, only a few biological activities have been experimentally tested; hence, further studies on the bioprospecting of animal compounds and ecological approaches are needed.</p>","PeriodicalId":49971,"journal":{"name":"Journal of Toxicology and Environmental Health-Part B-Critical Reviews","volume":" ","pages":"1-20"},"PeriodicalIF":7.2,"publicationDate":"2024-01-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"61566060","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Drug induced liver injury - a 2023 update. 药物诱导的肝损伤-2023年更新。
IF 7.2 2区 医学 Q1 ENVIRONMENTAL SCIENCES Pub Date : 2023-11-17 Epub Date: 2023-10-19 DOI: 10.1080/10937404.2023.2261848
Rebecca Allison, Asha Guraka, Isaac Thom Shawa, Gyan Tripathi, Wolfgang Moritz, Ali Kermanizadeh

Drug-Induced Liver Injury (DILI) constitutes hepatic damage attributed to drug exposure. DILI may be categorized as hepatocellular, cholestatic or mixed and might also involve immune responses. When DILI occurs in dose-dependent manner, it is referred to as intrinsic, while if the injury occurs spontaneously, it is termed as idiosyncratic. This review predominately focused on idiosyncratic liver injury. The established molecular mechanisms for DILI include (1) mitochondria dysfunction, (2) increased reactive oxygen species levels, (3) presence of elevated apoptosis and necrosis, (4) and bile duct injuries associated with immune mediated pathways. However, it should be emphasized that the underlying mechanisms responsible for DILI are still unknown. Prevention strategies are critical as incidences occur frequently, and treatment options are limited once the injury has developed. The aim of this review was to utilize retrospective cohort studies from across the globe to gain insight into epidemiological patterns. This review considers (1) what is currently known regarding the mechanisms underlying DILI, (2) discusses potential risk factors and (3) implications of the coronavirus pandemic on DILI presentation and research. Future perspectives are also considered and discussed and include potential new biomarkers, causality assessment and reporting methods.

药物性肝损伤(DILI)是由药物暴露引起的肝损伤。DILI可分为肝细胞性、胆汁淤积性或混合性,也可能涉及免疫反应。当DILI以剂量依赖的方式发生时,它被称为内在的,而如果损伤是自发发生的,则被称为特殊的。这篇综述主要集中在特异性肝损伤。DILI的既定分子机制包括(1)线粒体功能障碍,(2)活性氧水平增加,(3)细胞凋亡和坏死增加,(4)与免疫介导途径相关的胆管损伤。然而,应该强调的是,DILI的潜在机制仍然未知。预防策略至关重要,因为发生率很高,一旦损伤发生,治疗选择也很有限。这篇综述的目的是利用来自全球各地的回顾性队列研究来深入了解流行病学模式。这篇综述考虑了(1)目前已知的DILI的机制,(2)讨论了潜在的风险因素,以及(3)冠状病毒大流行对DILI表现和研究的影响。还考虑和讨论了未来的前景,包括潜在的新生物标志物、因果关系评估和报告方法。
{"title":"Drug induced liver injury - a 2023 update.","authors":"Rebecca Allison,&nbsp;Asha Guraka,&nbsp;Isaac Thom Shawa,&nbsp;Gyan Tripathi,&nbsp;Wolfgang Moritz,&nbsp;Ali Kermanizadeh","doi":"10.1080/10937404.2023.2261848","DOIUrl":"10.1080/10937404.2023.2261848","url":null,"abstract":"<p><p>Drug-Induced Liver Injury (DILI) constitutes hepatic damage attributed to drug exposure. DILI may be categorized as hepatocellular, cholestatic or mixed and might also involve immune responses. When DILI occurs in dose-dependent manner, it is referred to as intrinsic, while if the injury occurs spontaneously, it is termed as idiosyncratic. This review predominately focused on idiosyncratic liver injury. The established molecular mechanisms for DILI include (1) mitochondria dysfunction, (2) increased reactive oxygen species levels, (3) presence of elevated apoptosis and necrosis, (4) and bile duct injuries associated with immune mediated pathways. However, it should be emphasized that the underlying mechanisms responsible for DILI are still unknown. Prevention strategies are critical as incidences occur frequently, and treatment options are limited once the injury has developed. The aim of this review was to utilize retrospective cohort studies from across the globe to gain insight into epidemiological patterns. This review considers (1) what is currently known regarding the mechanisms underlying DILI, (2) discusses potential risk factors and (3) implications of the coronavirus pandemic on DILI presentation and research. Future perspectives are also considered and discussed and include potential new biomarkers, causality assessment and reporting methods.</p>","PeriodicalId":49971,"journal":{"name":"Journal of Toxicology and Environmental Health-Part B-Critical Reviews","volume":" ","pages":"442-467"},"PeriodicalIF":7.2,"publicationDate":"2023-11-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41118274","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Buthionine sulfoximine and chemoresistance in cancer treatments: a systematic review with meta-analysis of preclinical studies. 丁硫胺磺酰亚胺与癌症治疗中的化疗耐药性:临床前研究的系统综述和荟萃分析。
IF 7.2 2区 医学 Q1 ENVIRONMENTAL SCIENCES Pub Date : 2023-11-17 Epub Date: 2023-08-22 DOI: 10.1080/10937404.2023.2246876
Camila Dos Reis Oliveira, Joedna Cavalcante Pereira, Andressa Barros Ibiapina, Italo Rossi Roseno Martins, João Marcelo de Castro E Sousa, Paulo Michel Pinheiro Ferreira, Felipe Cavalcanti Carneiro da Silva

Buthionine sulfoximine (BSO) is a synthetic amino acid that blocks the biosynthesis of reduced glutathione (GSH), an endogenous antioxidant cellular component present in tumor cells. GSH levels have been associated with tumor cell resistance to chemotherapeutic drugs and platinum compounds. Consequently, by depleting GSH, BSO enhances the cytotoxicity of chemotherapeutic agents in drug-resistant tumors. Therefore, the aim of this study was to conduct a systematic review with meta-analysis of preclinical studies utilizing BSO in cancer treatments. The systematic search was carried out using the following databases: PubMed, Web of Science, Scopus, and EMBASE up until March 20, 2023, in order to collect preclinical studies that evaluated BSO, alone or in association, as a strategy for antineoplastic therapy. One hundred nine investigations were found to assess the cytotoxic potential of BSO alone or in combination with other compounds. Twenty-one of these met the criteria for performing the meta-analysis. The evidence gathered indicated that BSO alone exhibits cytotoxic activity. However, this compound is generally used in combination with other antineoplastic strategies, mainly chemotherapy ones, to improve cytotoxicity to carcinogenic cells and treatment efficacy. Finally, this review provides important considerations regarding BSO use in cancer treatment conditions, which might optimize future studies as a potential adjuvant antineoplastic therapeutic tool.

丁硫醚磺酰亚胺(BSO)是一种合成氨基酸,可阻断还原型谷胱甘肽(GSH)的生物合成,GSH是肿瘤细胞中存在的内源性抗氧化细胞成分。GSH水平与肿瘤细胞对化疗药物和铂化合物的耐药性有关。因此,通过消耗GSH,BSO增强了化疗药物在耐药肿瘤中的细胞毒性。因此,本研究的目的是对利用BSO治疗癌症的临床前研究进行系统综述和荟萃分析。截至2023年3月20日,使用以下数据库进行了系统搜索:PubMed、Web of Science、Scopus和EMBASE,以收集评估BSO单独或联合作为抗肿瘤治疗策略的临床前研究。发现109项研究评估了BSO单独或与其他化合物联合的细胞毒性潜力。其中21项符合进行荟萃分析的标准。收集到的证据表明,BSO单独表现出细胞毒性活性。然而,该化合物通常与其他抗肿瘤策略(主要是化疗策略)结合使用,以提高对致癌细胞的细胞毒性和治疗效果。最后,这篇综述提供了关于BSO在癌症治疗条件中的应用的重要考虑,这可能会优化未来作为潜在辅助抗肿瘤治疗工具的研究。
{"title":"Buthionine sulfoximine and chemoresistance in cancer treatments: a systematic review with meta-analysis of preclinical studies.","authors":"Camila Dos Reis Oliveira,&nbsp;Joedna Cavalcante Pereira,&nbsp;Andressa Barros Ibiapina,&nbsp;Italo Rossi Roseno Martins,&nbsp;João Marcelo de Castro E Sousa,&nbsp;Paulo Michel Pinheiro Ferreira,&nbsp;Felipe Cavalcanti Carneiro da Silva","doi":"10.1080/10937404.2023.2246876","DOIUrl":"10.1080/10937404.2023.2246876","url":null,"abstract":"<p><p>Buthionine sulfoximine (BSO) is a synthetic amino acid that blocks the biosynthesis of reduced glutathione (GSH), an endogenous antioxidant cellular component present in tumor cells. GSH levels have been associated with tumor cell resistance to chemotherapeutic drugs and platinum compounds. Consequently, by depleting GSH, BSO enhances the cytotoxicity of chemotherapeutic agents in drug-resistant tumors. Therefore, the aim of this study was to conduct a systematic review with meta-analysis of preclinical studies utilizing BSO in cancer treatments. The systematic search was carried out using the following databases: PubMed, Web of Science, Scopus, and EMBASE up until March 20, 2023, in order to collect preclinical studies that evaluated BSO, alone or in association, as a strategy for antineoplastic therapy. One hundred nine investigations were found to assess the cytotoxic potential of BSO alone or in combination with other compounds. Twenty-one of these met the criteria for performing the meta-analysis. The evidence gathered indicated that BSO alone exhibits cytotoxic activity. However, this compound is generally used in combination with other antineoplastic strategies, mainly chemotherapy ones, to improve cytotoxicity to carcinogenic cells and treatment efficacy. Finally, this review provides important considerations regarding BSO use in cancer treatment conditions, which might optimize future studies as a potential adjuvant antineoplastic therapeutic tool.</p>","PeriodicalId":49971,"journal":{"name":"Journal of Toxicology and Environmental Health-Part B-Critical Reviews","volume":" ","pages":"417-441"},"PeriodicalIF":7.2,"publicationDate":"2023-11-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10030531","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of the carcinogenicity of carbon tetrachloride. 四氯化碳致癌性的评价。
IF 7.2 2区 医学 Q1 ENVIRONMENTAL SCIENCES Pub Date : 2023-08-18 DOI: 10.1080/10937404.2023.2220147
Samuel M Cohen, Christopher Bevan, Bhaskar Gollapudi, James E Klaunig

Carbon tetrachloride (CCl4) has been extensively used and reported to produce toxicity, most notably involving the liver. Carbon tetrachloride metabolism involves CYP450-mediated bioactivation to trichloromethyl and trichloromethyl peroxy radicals, which are capable of macromolecular interaction with cell components including lipids and proteins. Radical interaction with lipids produces lipid peroxidation which can mediate cellular damage leading to cell death. Chronic exposure with CCl4 a rodent hepatic carcinogen with a mode of action (MOA) exhibits the following key events: 1) metabolic activation; 2) hepatocellular toxicity and cell death; 3) consequent regenerative increased cell proliferation; and 4) hepatocellular proliferative lesions (foci, adenomas, carcinomas). The induction of rodent hepatic tumors is dependent upon the dose (concentration and exposure duration) of CCl4, with tumors only occurring at cytotoxic exposure levels. Adrenal benign pheochromocytomas were also increased in mice at high CCl4 exposures; however, these tumors are not of relevant importance to human cancer risk. Few epidemiology studies that have been performed on CCl4, do not provide credible evidence of enhanced risk of occurrence of liver or adrenal cancers, but these studies have serious flaws limiting their usefulness for risk assessment. This manuscript summarizes the toxicity and carcinogenicity attributed to CCl4, specifically addressing MOA, dose-response, and human relevance.

四氯化碳(CCl4)已被广泛使用,并据报道产生毒性,最明显的是涉及肝脏。四氯化碳代谢涉及cyp450介导的三氯甲基和三氯甲基过氧自由基的生物活化,这些自由基能够与细胞成分(包括脂质和蛋白质)进行大分子相互作用。自由基与脂质相互作用产生脂质过氧化,可介导细胞损伤导致细胞死亡。慢性暴露于具有作用模式(MOA)的啮齿动物肝脏致癌物CCl4表现出以下关键事件:1)代谢激活;2)肝细胞毒性和细胞死亡;3)随之再生的细胞增殖增加;4)肝细胞增生性病变(病灶、腺瘤、癌)。啮齿动物肝脏肿瘤的诱导取决于CCl4的剂量(浓度和暴露时间),肿瘤仅在细胞毒性暴露水平下发生。高CCl4暴露小鼠肾上腺良性嗜铬细胞瘤也增加;然而,这些肿瘤与人类癌症风险无关。很少有关于CCl4的流行病学研究没有提供可信的证据表明肝癌或肾上腺癌的发生风险增加,但这些研究存在严重缺陷,限制了它们对风险评估的有用性。本文总结了CCl4的毒性和致癌性,特别是MOA、剂量反应和人类相关性。
{"title":"Evaluation of the carcinogenicity of carbon tetrachloride.","authors":"Samuel M Cohen,&nbsp;Christopher Bevan,&nbsp;Bhaskar Gollapudi,&nbsp;James E Klaunig","doi":"10.1080/10937404.2023.2220147","DOIUrl":"https://doi.org/10.1080/10937404.2023.2220147","url":null,"abstract":"<p><p>Carbon tetrachloride (CCl<sub>4</sub>) has been extensively used and reported to produce toxicity, most notably involving the liver. Carbon tetrachloride metabolism involves CYP450-mediated bioactivation to trichloromethyl and trichloromethyl peroxy radicals, which are capable of macromolecular interaction with cell components including lipids and proteins. Radical interaction with lipids produces lipid peroxidation which can mediate cellular damage leading to cell death. Chronic exposure with CCl<sub>4</sub> a rodent hepatic carcinogen with a mode of action (MOA) exhibits the following key events: 1) metabolic activation; 2) hepatocellular toxicity and cell death; 3) consequent regenerative increased cell proliferation; and 4) hepatocellular proliferative lesions (foci, adenomas, carcinomas). The induction of rodent hepatic tumors is dependent upon the dose (concentration and exposure duration) of CCl<sub>4</sub>, with tumors only occurring at cytotoxic exposure levels. Adrenal benign pheochromocytomas were also increased in mice at high CCl<sub>4</sub> exposures; however, these tumors are not of relevant importance to human cancer risk. Few epidemiology studies that have been performed on CCl<sub>4</sub>, do not provide credible evidence of enhanced risk of occurrence of liver or adrenal cancers, but these studies have serious flaws limiting their usefulness for risk assessment. This manuscript summarizes the toxicity and carcinogenicity attributed to CCl<sub>4</sub>, specifically addressing MOA, dose-response, and human relevance.</p>","PeriodicalId":49971,"journal":{"name":"Journal of Toxicology and Environmental Health-Part B-Critical Reviews","volume":"26 6","pages":"342-370"},"PeriodicalIF":7.2,"publicationDate":"2023-08-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10334952","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Toxicological and pharmacokinetic properties of sucralose-6-acetate and its parent sucralose: in vitro screening assays. 三氯蔗糖-6-乙酸酯及其母体三氯蔗糖的毒理学和药代动力学特性:体外筛选试验。
IF 7.2 2区 医学 Q1 ENVIRONMENTAL SCIENCES Pub Date : 2023-08-18 DOI: 10.1080/10937404.2023.2213903
Susan S Schiffman, Elizabeth H Scholl, Terrence S Furey, H Troy Nagle

The purpose of this study was to determine the toxicological and pharmacokinetic properties of sucralose-6-acetate, a structural analog of the artificial sweetener sucralose. Sucralose-6-acetate is an intermediate and impurity in the manufacture of sucralose, and recent commercial sucralose samples were found to contain up to 0.67% sucralose-6-acetate. Studies in a rodent model found that sucralose-6-acetate is also present in fecal samples with levels up to 10% relative to sucralose which suggest that sucralose is also acetylated in the intestines. A MultiFlow® assay, a high-throughput genotoxicity screening tool, and a micronucleus (MN) test that detects cytogenetic damage both indicated that sucralose-6-acetate is genotoxic. The mechanism of action was classified as clastogenic (produces DNA strand breaks) using the MultiFlow® assay. The amount of sucralose-6-acetate in a single daily sucralose-sweetened drink might far exceed the threshold of toxicological concern for genotoxicity (TTCgenotox) of 0.15 µg/person/day. The RepliGut® System was employed to expose human intestinal epithelium to sucralose-6-acetate and sucralose, and an RNA-seq analysis was performed to determine gene expression induced by these exposures. Sucralose-6-acetate significantly increased the expression of genes associated with inflammation, oxidative stress, and cancer with greatest expression for the metallothionein 1 G gene (MT1G). Measurements of transepithelial electrical resistance (TEER) and permeability in human transverse colon epithelium indicated that sucralose-6-acetate and sucralose both impaired intestinal barrier integrity. Sucralose-6-acetate also inhibited two members of the cytochrome P450 family (CYP1A2 and CYP2C19). Overall, the toxicological and pharmacokinetic findings for sucralose-6-acetate raise significant health concerns regarding the safety and regulatory status of sucralose itself.

本研究的目的是确定三氯蔗糖-6-乙酸酯的毒理学和药代动力学性质,三氯蔗糖是一种结构类似于人工甜味剂三氯蔗糖的物质。三氯蔗糖-6-乙酸是生产三氯蔗糖的中间体和杂质,最近的商业三氯蔗糖样品被发现含有高达0.67%的三氯蔗糖-6-乙酸。在啮齿动物模型中进行的研究发现,粪便样本中也存在三氯蔗糖-6-乙酸酯,其含量高达三氯蔗糖的10%这表明三氯蔗糖在肠道中也会乙酰化。高通量遗传毒性筛选工具MultiFlow®测定和检测细胞遗传损伤的微核(MN)试验均表明三氯蔗糖-6-乙酸酯具有遗传毒性。使用MultiFlow®检测,作用机制被归类为致裂性(产生DNA链断裂)。每日一次含三氯蔗糖饮料中三氯蔗糖-6-乙酸酯的含量可能远远超过基因毒性毒理学关注的阈值(TTCgenotox) 0.15µg/人/天。使用RepliGut®系统将人肠上皮暴露于三氯蔗糖-6-乙酸和三氯蔗糖中,并进行RNA-seq分析以确定这些暴露诱导的基因表达。三氯蔗糖-6-乙酸显著增加炎症、氧化应激和癌症相关基因的表达,其中金属硫蛋白1g基因(MT1G)表达最多。人横结肠上皮经上皮电阻(TEER)和通透性的测量表明,三氯蔗糖-6-醋酸酯和三氯蔗糖都损害了肠屏障的完整性。三氯蔗糖-6-乙酸也抑制细胞色素P450家族的两个成员(CYP1A2和CYP2C19)。总的来说,三氯蔗糖-6-乙酸酯的毒理学和药代动力学研究结果引起了对三氯蔗糖本身安全性和监管地位的重大健康关注。
{"title":"Toxicological and pharmacokinetic properties of sucralose-6-acetate and its parent sucralose: <i>in vitro</i> screening assays.","authors":"Susan S Schiffman,&nbsp;Elizabeth H Scholl,&nbsp;Terrence S Furey,&nbsp;H Troy Nagle","doi":"10.1080/10937404.2023.2213903","DOIUrl":"https://doi.org/10.1080/10937404.2023.2213903","url":null,"abstract":"<p><p>The purpose of this study was to determine the toxicological and pharmacokinetic properties of sucralose-6-acetate, a structural analog of the artificial sweetener sucralose. Sucralose-6-acetate is an intermediate and impurity in the manufacture of sucralose, and recent commercial sucralose samples were found to contain up to 0.67% sucralose-6-acetate. Studies in a rodent model found that sucralose-6-acetate is also present in fecal samples with levels up to 10% relative to sucralose which suggest that sucralose is also acetylated in the intestines. A MultiFlow® assay, a high-throughput genotoxicity screening tool, and a micronucleus (MN) test that detects cytogenetic damage both indicated that sucralose-6-acetate is genotoxic. The mechanism of action was classified as clastogenic (produces DNA strand breaks) using the MultiFlow® assay. The amount of sucralose-6-acetate in a single daily sucralose-sweetened drink might far exceed the threshold of toxicological concern for genotoxicity (TTC<sub>genotox</sub>) of 0.15 µg/person/day. The RepliGut® System was employed to expose human intestinal epithelium to sucralose-6-acetate and sucralose, and an RNA-seq analysis was performed to determine gene expression induced by these exposures. Sucralose-6-acetate significantly increased the expression of genes associated with inflammation, oxidative stress, and cancer with greatest expression for the metallothionein 1 G gene (MT1G). Measurements of transepithelial electrical resistance (TEER) and permeability in human transverse colon epithelium indicated that sucralose-6-acetate and sucralose both impaired intestinal barrier integrity. Sucralose-6-acetate also inhibited two members of the cytochrome P450 family (CYP1A2 and CYP2C19). Overall, the toxicological and pharmacokinetic findings for sucralose-6-acetate raise significant health concerns regarding the safety and regulatory status of sucralose itself.</p>","PeriodicalId":49971,"journal":{"name":"Journal of Toxicology and Environmental Health-Part B-Critical Reviews","volume":"26 6","pages":"307-341"},"PeriodicalIF":7.2,"publicationDate":"2023-08-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9965394","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
期刊
Journal of Toxicology and Environmental Health-Part B-Critical Reviews
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1